José Dias

573 total citations
29 papers, 454 citations indexed

About

José Dias is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, José Dias has authored 29 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 13 papers in Molecular Biology and 10 papers in Computational Theory and Mathematics. Recurrent topics in José Dias's work include Cholinesterase and Neurodegenerative Diseases (20 papers), Computational Drug Discovery Methods (10 papers) and Pesticide Exposure and Toxicity (10 papers). José Dias is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (20 papers), Computational Drug Discovery Methods (10 papers) and Pesticide Exposure and Toxicity (10 papers). José Dias collaborates with scholars based in France, Slovenia and China. José Dias's co-authors include Florian Nachon, Marc Mirande, Martine Comisso, Ludovic Jean, Pierre‐Yves Renard, Jean Demarquoy, Pia D. Vogel, Javier Pérez, Richard C. D. Brown and Louis Renault and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemistry.

In The Last Decade

José Dias

28 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José Dias France 13 235 176 128 119 96 29 454
Petr Jošt Czechia 10 255 1.1× 83 0.5× 171 1.3× 97 0.8× 132 1.4× 20 427
Maricarmen Hernández‐Rodríguez Mexico 13 117 0.5× 194 1.1× 134 1.0× 54 0.5× 92 1.0× 31 480
Arie Lazar Israel 5 336 1.4× 114 0.6× 232 1.8× 133 1.1× 133 1.4× 5 401
Abraham Madariaga‐Mazón Mexico 13 108 0.5× 232 1.3× 110 0.9× 48 0.4× 86 0.9× 32 461
Alessandro Pesaresi Italy 11 257 1.1× 192 1.1× 194 1.5× 43 0.4× 121 1.3× 17 495
B.P. Doctor United States 8 384 1.6× 162 0.9× 190 1.5× 230 1.9× 59 0.6× 11 484
Merve Baysal Türkiye 14 103 0.4× 122 0.7× 71 0.6× 18 0.2× 247 2.6× 34 567
Halide Edip Temel Türkiye 16 143 0.6× 162 0.9× 127 1.0× 85 0.7× 434 4.5× 58 702
Rohit Kumar India 6 116 0.5× 128 0.7× 46 0.4× 71 0.6× 47 0.5× 19 340
Ashish Wadhwani India 11 40 0.2× 131 0.7× 45 0.4× 72 0.6× 75 0.8× 30 391

Countries citing papers authored by José Dias

Since Specialization
Citations

This map shows the geographic impact of José Dias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Dias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Dias more than expected).

Fields of papers citing papers by José Dias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Dias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Dias. The network helps show where José Dias may publish in the future.

Co-authorship network of co-authors of José Dias

This figure shows the co-authorship network connecting the top 25 collaborators of José Dias. A scholar is included among the top collaborators of José Dias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Dias. José Dias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dias, José, et al.. (2025). Specific Rosetta-based protein-peptide prediction protocol allows the design of novel cholinesterase inhibitor peptides. Bioorganic Chemistry. 156. 108202–108202. 2 indexed citations
2.
Košak, Urban, Damijan Knez, Anja Pišlar, et al.. (2025). Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease. Chemico-Biological Interactions. 420. 111670–111670.
3.
Košak, Urban, Damijan Knez, Anja Pišlar, et al.. (2025). N-Propargylpyrrolidine-based butyrylcholinesterase and monoamine oxidase inhibitors. Chemico-Biological Interactions. 420. 111681–111681. 1 indexed citations
4.
Šinko, Goran, Ludovic Jean, Mourad Chioua, et al.. (2024). Cholesterol Oxime Olesoxime Assessed as a Potential Ligand of Human Cholinesterases. Biomolecules. 14(5). 588–588. 1 indexed citations
5.
Dias, José, et al.. (2024). The risk associated with organophosphorus nerve agents: from their discovery to their unavoidable threat, current medical countermeasures and perspectives. Chemico-Biological Interactions. 395. 110973–110973. 16 indexed citations
6.
Dias, José, et al.. (2023). Inhibition of Human Cholinesterases and in vitro β‐Amyloid Aggregation by Rationally Designed Peptides. ChemMedChem. 18(12). e202200691–e202200691. 3 indexed citations
7.
Knez, Damijan, Xavier Brazzolotto, Florian Nachon, et al.. (2022). From tryptophan-based amides to tertiary amines: Optimization of a butyrylcholinesterase inhibitor series. European Journal of Medicinal Chemistry. 234. 114248–114248. 21 indexed citations
8.
Probst, Nicolas, Christophe Landry, Caroline Coisne, et al.. (2022). A New Class of Bi- and Trifunctional Sugar Oximes as Antidotes against Organophosphorus Poisoning. Journal of Medicinal Chemistry. 65(6). 4649–4666. 14 indexed citations
9.
Chavarria, Daniel, Sofia Benfeito, Jorge Garrido, et al.. (2021). Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases. Antioxidants. 10(2). 329–329. 10 indexed citations
10.
Pasieka, Anna, Dawid Panek, Jakub Jończyk, et al.. (2021). Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters. European Journal of Medicinal Chemistry. 218. 113397–113397. 16 indexed citations
11.
Kapure, Jeevak Sopanrao, Girdhar Singh Deora, José Dias, et al.. (2020). Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 30(24). 127609–127609. 8 indexed citations
12.
Zueva, Irina V., José Dias, Sofya V. Lushchekina, et al.. (2019). New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease. Neuropharmacology. 155. 131–141. 79 indexed citations
13.
Santoni, Gianluca, E. De la Mora, José Dias, et al.. (2018). Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents. Journal of Medicinal Chemistry. 61(17). 7630–7639. 46 indexed citations
14.
15.
16.
Dias, José, Louis Renault, Javier Pérez, & Marc Mirande. (2013). Small-angle X-ray Solution Scattering Study of the Multi-aminoacyl-tRNA Synthetase Complex Reveals an Elongated and Multi-armed particle. Journal of Biological Chemistry. 288(33). 23979–23989. 27 indexed citations
17.
18.
Dias, José & Pia D. Vogel. (2009). Effects of Small Molecule Modulators on ATP Binding to Skeletal Ryanodine Receptor. The Protein Journal. 28(5). 240–246. 7 indexed citations
19.
Rigault, Caroline, José Dias, Jean Demarquoy, & Françoise Le Borgne. (2007). Characteristics of l-carnitine import into heart cells. Biochimie. 90(3). 542–546. 12 indexed citations
20.
Galland, Stéphane, Béatrice Georges, Florent Le Borgne, et al.. (2002). Thyroid hormone controls carnitine status through modifications of γ-butyrobetaine hydroxylase activity and gene expression. Cellular and Molecular Life Sciences. 59(3). 540–545. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petr Jošt Breakdown of academic impact, for papers by Maricarmen Hernández‐Rodríguez Breakdown of academic impact, for papers by Arie Lazar Breakdown of academic impact, for papers by Abraham Madariaga‐Mazón Breakdown of academic impact, for papers by Alessandro Pesaresi Breakdown of academic impact, for papers by B.P. Doctor Breakdown of academic impact, for papers by Merve Baysal Breakdown of academic impact, for papers by Halide Edip Temel Breakdown of academic impact, for papers by Rohit Kumar Breakdown of academic impact, for papers by Ashish Wadhwani
Rankless by CCL
2026